Mutation of the Lyn tyrosine kinase delays the progression of Friend virus induced erythroleukemia without affecting susceptibility

Leukemia Research

Volumn 30, Issue 9, 2006, Pages 1141-1149

  Subramanian, Aparna ^a   Hegde, Shailaja ^a   Correll, Pamela H ^a   Paulson, Robert F ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Friend virus; Leukemia; Src family kinases

Indexed keywords

ERYTHROPOIETIN; PROTEIN KINASE LYN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CANCER SUSCEPTIBILITY; CELL DIFFERENTIATION; CELL TRANSFORMATION; COLONY FORMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME DEFICIENCY; ERYTHROBLAST; ERYTHROLEUKEMIA; FRIEND LEUKEMIA VIRUS; GENE MUTATION; GENETIC SUSCEPTIBILITY; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; PATHOGENESIS; POLYCYTHEMIA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLEEN; SPLEEN CELL; SPLENOMEGALY; VIRUS CARCINOGENESIS; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS STRAIN;

ANIMALS; BONE MARROW; CELL DIFFERENTIATION; CELL TRANSFORMATION, VIRAL; ERYTHROID PROGENITOR CELLS; FRIEND MURINE LEUKEMIA VIRUS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; LEUKEMIA, EXPERIMENTAL; MAP KINASE SIGNALING SYSTEM; MICE; MICE, KNOCKOUT; MUTATION; PHOSPHOTRANSFERASES; RECEPTORS, ERYTHROPOIETIN; RETROVIRIDAE INFECTIONS; SPLEEN; SRC-FAMILY KINASES; TUMOR VIRUS INFECTIONS; VIRAL ENVELOPE PROTEINS;

EID: 33745865511     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.02.006     Document Type: Article

References (62)

1. Friend C. Cell-free transmission in adult Swiss mice of a disease having the character of a leukemia. J Exp Med 105 (1957) 307-318
2. Mirand E.A., Steeves R.A., Lange R.D., and Grace Jr. J.T. Virus-induced polycythemia in mice: erythropoiesis without erythropoietin. Proc Soc Exp Biol Med 128 (1968) 844-849
3. Ben-David Y., and Bernstein A. Friend virus-induced erythroleukemia and the multistage nature of cancer. Cell 66 (1991) 831-834
4. Li J.P., D'Andrea A.D., Lodish H.F., and Baltimore D. Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor. Nature 343 (1990) 762-764
5. Hoatlin M.E., and Kabat D. Host-range control of a retroviral disease: Friend erythroleukemia. Trends Microbiol 3 (1995) 51-57
6. Nishigaki K., Thompson D., Hanson C., Yugawa T., and Ruscetti S. The envelope glycoprotein of friend spleen focus-forming virus covalently interacts with and constitutively activates a truncated form of the receptor tyrosine kinase Stk. J Virol 75 (2001) 7893-7903
7. Persons D.A., Paulson R.F., Loyd M.R., Herley M.T., Bodner S.M., Bernstein A., et al. Fv2 encodes a truncated form of the Stk receptor tyrosine kinase. Nat Genet 23 (1999) 159-165
8. Tambourin P., and Wendling F. Malignant transformation and erythroid differentiation by polycythaemia-inducing Friend virus. Nat New Biol 234 (1971) 230-233
9. Horoszewicz J.S., Leong S.S., and Carter W.A. Friend leukemia: rapid development of erythropoietin-independent hematopoietic precursors. J Natl Cancer Inst 54 (1975) 265-267
10. Liao S.K., and Axelrad A.A. Erythropoietin-independent erythroid colony formation in vitro by hemopoietic cells of mice infected with friend virus. Int J Cancer 15 (1975) 467-482
11. Mowat M., Cheng A., Kimura N., Bernstein A., and Benchimol S. Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus. Nature 314 (1985) 633-636
12. Moreau-Gachelin F., Tavitian A., and Tambourin P. Spi-1 is a putative oncogene in virally induced murine erythroleukaemias. Nature 331 (1988) 277-280
13. Lilly F., and Pincus T. Genetic control of murine viral leukemogenesis. Adv Cancer Res 17 (1973) 231-277
14. Axelrad A. Genetic and cellular basis of susceptibility or resistance to Friend leukemia virus infection in mice. Proc Can Cancer Conf 8 (1969) 313-343
15. Ikeda H., and Sugimura H. Fv-4 resistance gene: a truncated endogenous murine leukemia virus with ecotropic interference properties. J Virol 63 (1989) 5405-5412
16. Best S., Le Tissier P., Towers G., and Stoye J.P. Positional cloning of the mouse retrovirus restriction gene Fv1. Nature 382 (1996) 826-829
17. Bennett M., Steeves R.A., Cudkowicz G., Mirand E.A., and Russell L.B. Mutant Sl alleles of mice affect susceptibility to Friend spleen focus-forming virus. Science 162 (1968) 564-565
18. Lilly F. Fv2: identification and location of a second gene governing the spleen focus response to Friend leukemia virus in mice. J Natl Cancer Inst 45 (1970) 163-169
19. Lenox L., Perry J., and Paulson R. BMP4 and Madh5 regulate the erythroid response to acute anemia. Blood 105 (2005) 2741-2748
20. Steeves R.A., Bennett M., Mirand E.A., and Cudkowicz G. Genetic control by the W locus of susceptibility to (Friend) spleen focus-forming virus. Nature 218 (1968) 372-374
21. Berhringer R., and Dewey M. Cellular site and mode of Fv-2 action. Cell 40 (1985) 441-447
22. Zhang J., Randall M.S., Loyd M.R., Li W., Schweers R.L., Persons D.A., et al. Role of erythropoietin receptor signaling in Friend virus-induced erythroblastosis and polycythemia. Blood 107 (2006) 73-78
23. Miura O., Nakamura N., Quelle F.W., Witthuhn B.A., Ihle J.N., and Aoki N. Erythropoietin induces association of the JAK2 protein tyrosine kinase with the erythropoietin receptor in vivo. Blood 84 (1994) 1501-1507
24. Witthuhn B.A., Quelle F.W., Silvennoinen O., Yi T., Tang B., Miura O., et al. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74 (1993) 227-236
25. Damen J.E., Mui A.L., Puil L., Pawson T., and Krystal G. Phosphatidylinositol 3-kinase associates, via its Src homology 2 domains, with the activated erythropoietin receptor. Blood 81 (1993) 3204-3210
26. Carroll M.P., Spivak J.L., McMahon M., Weich N., Rapp U.R., and May W.S. Erythropoietin induces Raf-1 activation and Raf-1 is required for erythropoietin-mediated proliferation. J Biol Chem 266 (1991) 14964-14969
27. Ohashi T., Masuda M., and Ruscetti S.K. Constitutive activation of Stat-related DNA-binding proteins in erythroid cells by the Friend spleen focus-forming virus. Leukemia 11 Suppl 3 (1997) 251-254
28. Yamamura Y., Senda H., Noda M., and Ikawa Y. Activation of the JAK1-STAT5 pathway by binding of the Friend virus gp55 glycoprotein to the erythropoietin receptor. Leukemia 11 Suppl. 3 (1997) 432-434
29. Yamamura Y., Senda H., Kageyama Y., Matsuzaki T., Noda M., and Ikawa Y. Erythropoietin and Friend virus gp55 activate different JAK/STAT pathways through the erythropoietin receptor in erythroid cells. Mol Cell Biol 18 (1998) 1172-1180
30. Nishigaki K., Hanson C., Ohashi T., Thompson D., Muszynski K., and Ruscetti S. Erythroid cells rendered erythropoietin independent by infection with Friend spleen focus-forming virus show constitutive activation of phosphatidylinositol 3-kinase and Akt kinase: involvement of insulin receptor substrate-related adapter proteins. J Virol 74 (2000) 3037-3045
31. Barnache S., Mayeux P., Payrastre B., and Moreau-Gachelin F. Alterations of the phosphoinositide 3-kinase and mitogen-activated protein kinase signaling pathways in the erythropoietin-independent Spi-1/PU.1 transgenic proerythroblasts. Blood 98 (2001) 2372-2381
32. Finkelstein L., Ney P., Liu Q., Paulson R., and Correll P. Sf-Stk kinase activity and the Grb2 binding site are required for Epo-independent growth of primary erythroblasts infected with Friend virus. Oncogene 21 (2002) 3562-3570
33. Iwama A., Okano K., Sudo T., Matsuda Y., and Suda T. Molecular cloning of a novel receptor tyrosine kinase gene, STK, derived from enriched hematopoietic stem cells. Blood 83 (1994) 3160-3169
34. Okutani Y., Kitanaka A., Tanaka T., Kamano H., Ohnishi H., Kubota Y., et al. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway. Oncogene 20 (2001) 6643-6650
35. Kubota Y., Tanaka T., Kitanaka A., Ohnishi H., Okutani Y., Waki M., et al. Src transduces erythropoietin-induced differentiation signals through phosphatidylinositol 3-kinase. EMBO J 20 (2001) 5666-5677
36. Anderson S.M., and Scolnick E.M. Construction and isolation of a transforming murine retrovirus containing the src gene of Rous sarcoma virus. J Virol 46 (1983) 594-605
37. Anderson S.M., Klinken S.P., and Hankins W.D. A murine recombinant retrovirus containing the src oncogene transforms erythroid precursor cells in vitro. Mol Cell Biol 5 (1985) 3369-3375
38. Chin H., Arai A., Wakao H., Kamiyama R., Miyasaka N., and Miura O. Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway. Blood 91 (1998) 3734-3745
39. Tilbrook P.A., Ingley E., Williams J.H., Hibbs M.L., and Klinken S.P. Lyn tyrosine kinase is essential for erythropoietin-induced differentiation of J2E erythroid cells. EMBO J 16 (1997) 1610-1619
40. Tilbrook P.A., Palmer G.A., Bittorf T., McCarthy D.J., Wright M.J., Sarna M.K., et al. Maturation of erythroid cells and erythroleukemia development are affected by the kinase activity of Lyn. Cancer Res 61 (2001) 2453-2458
41. Harder K.W., Quilici C., Naik E., Inglese M., Kountouri N., Turner A., et al. Perturbed myelo/erythropoiesis in Lyn-deficient mice is similar to that in mice lacking the inhibitory phosphatases SHP-1 and SHIP-1. Blood 104 (2004) 3901-3910
42. Ingley E., McCarthy D.J., Pore J.R., Sarna M.K., Adenan A.S., Wright M.J., et al. Lyn deficiency reduces GATA-1, EKLF and STAT5, and induces extramedullary stress erythropoiesis. Oncogene 24 (2005) 336-343
43. Chan V.W., Meng F., Soriano P., DeFranco A.L., and Lowell C.A. Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation. Immunity 7 (1997) 69-81
44. Mager D.L., Mak T.W., and Bernstein A. Quantitative colony method for tumorigenic cells transformed by two distinct strains of Friend leukemia virus. Proc Natl Acad Sci USA 78 (1981) 1703-1707
45. Axelrad A.A., and Steeves R.A. Assay for Friend leukemia virus: rapid quantitative method based on enumeration of macroscopic spleen foci in mice. Virology 24 (1964) 513-518
46. Mager D., MacDonald M.E., Robson I.B., Mak T.W., and Bernstein A. Clonal analysis of the late stages of erythroleukemia induced by two distinct strains of Friend leukemia virus. Mol Cell Biol 1 (1981) 721-730
47. Tan B.L., Hong L., Munugalavadla V., and Kapur R. Functional and biochemical consequences of abrogating the activation of multiple diverse early signaling pathways in Kit. Role for Src kinase pathway in Kit-induced cooperation with erythropoietin receptor. J Biol Chem 278 (2003) 11686-11695
48. Linnekin D., DeBerry C.S., and Mou S. Lyn associates with the juxtamembrane region of c-Kit and is activated by stem cell factor in hematopoietic cell lines and normal progenitor cells. J Biol Chem 272 (1997) 27450-27455
49. Corey S.J., and Anderson S.M. Src-related protein tyrosine kinases in hematopoiesis. Blood 93 (1999) 1-14
50. Kitanaka A., Waki M., Kamano H., Tanaka T., Kubota Y., Ohnishi H., et al. Antisense src expression inhibits proliferation and erythropoietin-induced erythroid differentiation of K562 human leukemia cells. Biochem Biophys Res Commun 201 (1994) 1534-1540
51. Ghaffari S., Wu H., Gerlach M., Han Y., Lodish H.F., and Daley G.Q. BCR-ABL and v-SRC tyrosine kinase oncoproteins support normal erythroid development in erythropoietin receptor-deficient progenitor cells. Proc Natl Acad Sci USA 96 (1999) 13186-13190
52. Robinson D., Chen H.C., Li D., Yustein J.T., He F., Lin W.C., et al. Tyrosine kinase expression profiles of chicken erythro-progenitor cells and oncogene-transformed erythroblasts. J Biomed Sci 5 (1998) 93-100
53. Brunati A.M., Bordin L., Clari G., James P., Quadroni M., Baritono E., et al. Sequential phosphorylation of protein band 3 by Syk and Lyn tyrosine kinases in intact human erythrocytes: identification of primary and secondary phosphorylation sites. Blood 96 (2000) 1550-1557
54. Hankins W.D., Kost T.A., Koury M.J., and Krantz S.B. Erythroid bursts produced by Friend leukaemia virus in vitro. Nature 276 (1978) 506-508
55. Kost T.A., Koury M.J., Hankins W.D., and Krantz S.B. Target cells for Friend virus-induced erythroid bursts in vitro. Cell 18 (1979) 145-152
56. Kost T.A., Koury M.J., and Krantz S.B. Mature erythroid burst-forming units are target cells for Friend virus-induced erythroid bursts. Virology 108 (1981) 309-317
57. Shibuya T., and Mak T.W. A host gene controlling early anaemia or polycythaemia induced by Friend erythroleukaemia virus. Nature 296 (1982) 577-579
58. Shibuya T., Niho Y., and Mak T.W. Erythroleukemia induction by Friend leukemia virus. A host gene locus controlling early anemia or polycythemia and the rate of proliferation of late erythroid cells. J Exp Med 156 (1982) 398-414
59. Quang C.T., Wessely O., Pironin M., Beug H., and Ghysdael J. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation. EMBO J 16 (1997) 5639-5653
60. O'Laughlin-Bunner B., Radosevic N., Taylor M.L., Shivakrupa, DeBerry C., Metcalfe D.D., et al. Lyn is required for normal stem cell factor-induced proliferation and chemotaxis of primary hematopoietic cells. Blood 98 (2001) 343-350
61. Hu Y., Liu Y., Pelletier S., Buchdunger E., Warmuth M., Fabbro D., et al. Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia. Nat Genet 36 (2004) 453-461
62. Ptasznik A., Nakata Y., Kalota A., Emerson S.G., and Gewirtz A.M. Short interfering RNA (siRNA) targeting the Lyn kinase induces apoptosis in primary, and drug-resistant, BCR-ABL1(+) leukemia cells. Nat Med 10 (2004) 1187-1189